ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
N24-009,Melatonin,CYP1A2,"Minor – result should be considered as may affect medicationresponse",NA
N24-009,Moclobemide,CYP2C19,"Minor – result should be considered as may affect medicationresponse","INCREASED RISK OF SEROTONIN TOXICITY WITH ZOLMITRIPTAN, INHIBITOR MODERATE: CYP2C19, INHIBITOR MODERATE: CYP2D6"
N24-009,Codeine (component of Acetaminophen-Caffeine-Codeine),"CYP2D6OPRM1",Usual prescribing considerations apply,NA
N24-009,Diclofenac (Viclofen),CYP2C9,Usual prescribing considerations apply,NA
N24-009,Quetiapine (component of Seroquel),CYP3A4,Usual prescribing considerations apply,NA
N24-009,Rosuvastatin,SLCO1B1,Usual prescribing considerations apply,NA
N24-009,hydromorphone hydrochloride,NA,NO,NA
N24-009, tamsulosin,NA,NO,NA
N24-009, dutasteride,NA,NO,NA
N24-009, fluticasone (Avamys),NA,NO,NA
N24-009, budesonide / eformoterol fumarate dihydrate (Symbicort Turbuhaler),NA,NO,NA
N24-009, levothyroxine sodium (Levothyroxine Sodium For Injection),NA,NO,NA
N24-009, zolmitriptan,NA,NO,INCREASED RISK OF SEROTONIN TOXICITY WITH MOCLOBEMIDE
N24-009, hydromorphone hydrochloride (Dilaudid),NA,NO,NA
N24-009, hydrocortisone,NA,NO,NA
N24-009, acetaminophen (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
N24-009, caffeine (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
